Haleon plc (HLN) Financials

HLN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 43.4 billion 22.1 billion
2023-09-30 ? ?
2023-06-30 43.1 billion 22.2 billion
2023-03-31 ? ?

HLN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-09-30 ? ?
2023-06-30 ? ?
2023-03-31 ? ?

HLN Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -3.8 million
2023-09-30 445.2 million
2023-06-30 376.2 million
2023-03-31 482.0 million

HLN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 597.7 million - -
2023-06-30 618.6 million 11.1 billion 184.3 million
2023-03-31 847.5 million - -

HLN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 11.8 billion
2023-09-30 5.6 billion
2023-06-30 5.8 billion
2023-03-31 5.7 billion

HLN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 119.8 million 1.4 billion -
2023-09-30 - 91.5 million 1.3 billion -
2023-06-30 181.8 million 84.6 million 1.4 billion -
2023-03-31 - 92.9 million 1.4 billion -

HLN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.5 billion 1.6 billion
2023-09-30 3.4 billion 1.3 billion
2023-06-30 3.5 billion 1.3 billion
2023-03-31 3.7 billion 1.4 billion

HLN

Price: $8.47

52 week price:
7.70
9.05

Dividend Yield: 0.01%

5-year range yield:
0.01%
2.52%

Forward Dividend Yield: 2.52%

Payout Ratio: 62.56%

Payout Ratio Range:
20.91%
62.56%

Dividend Per Share: 0.21 USD

Earnings Per Share: 0.29 USD

P/E Ratio: 24.65

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 23.3 million

Market Capitalization: 37.9 billion

Years Paying Dividends: 2

Links: